Clinical Trials Logo

Clinical Trial Summary

To evaluate the long-term safety and tolerability of oral dersimelagon.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05005975
Study type Interventional
Source Mitsubishi Tanabe Pharma America Inc.
Contact
Status Active, not recruiting
Phase Phase 3
Start date August 10, 2021
Completion date June 2025

See also
  Status Clinical Trial Phase
Completed NCT04402489 - Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria Phase 3
Completed NCT01688895 - Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Completed NCT02979249 - Oral Iron for Erythropoietic Protoporphyrias N/A